Tetralogy of fallot prevention: Difference between revisions
No edit summary |
|||
| Line 30: | Line 30: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 16:18, 5 March 2013
|
Tetralogy of fallot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
|
|
Tetralogy of fallot prevention On the Web |
|
American Roentgen Ray Society Images of Tetralogy of fallot prevention |
|
Risk calculators and risk factors for Tetralogy of fallot prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]
Overview
Factors that reduce systemic vascular resistance (SVR) may exacerbate shunting which in turn exacerbates cyanosis and should be avoided if at all possible in the patient with Tetralogy of Fallot.
Prevention
No known prevention exists for Tetralogy of Fallot.
Prevention of Cyanosis
The following factors may reduce systemic vascular resistance (SVR) and exacerbate shunting which in turn exacerbate cyanosis and should be avoided if at all possible:
- Acidosis
- Bathing in hot water
- Fever
- Stress
- Infection
- Posture (upright, not squatting)
- Exercise
- Beta-adrenergic agonists
- Dehydration
- Closure of the patent ductus arteriosus
Prevention of Infective Endocarditis
- Antibiotic prophylaxis should be administered.